New Key Statistics Module, Z-Score and F-Score
NAS:STOK Key Ratios
| Market Cap $ M | 687.05 |
| Enterprise Value $ M | 409.98 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.81 |
| Price/Sales | 41.44 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 15.00 |
| EPS (TTM) $ | -2.18 |
| Beneish M-Score | -2.2 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -29.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.62 |
| EV-to-EBITDA | -3.70 |
| PEG | -- |
| Shares Outstanding M | 52.65 |
| Net Margin (%) | -683.31 |
| Operating Margin % | -755.65 |
| Pre-tax Margin (%) | -683.31 |
| Quick Ratio | 6.67 |
| Current Ratio | 6.67 |
| ROA % (ttm) | -41.83 |
| ROE % (ttm) | -57.17 |
| ROIC % (ttm) | -337.71 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.22 |
STOK Number of Guru Trades
STOK Volume of Guru Trades
Gurus Latest Trades with NAS:STOK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:STOK is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Stoke Therapeutics Inc Insider Transactions
No Available Data
News about NAS:STOK
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers